Clinical Trials Browser

Phase 1 × valrubicin × Clear all

NCT01606345 2016-04-22

Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma

Phase 1 Completed

Carcinoma, Transitional Cell, Neoplasms